"Assessment of Sedation Depth Using Processed EEG in ICU Patients With ARDS Receiving Neuromuscular Blockade: A Prospective Observational Study"

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 17, 2024

Study Completion Date

April 24, 2024

Conditions
Sedation ComplicationAcute Respiratory Distress Syndrome Due to COVID-19Anesthesia Awareness
Interventions
PROCEDURE

Depth of sedation monitoring

In the study, group rates of patient state index (PSI) \[(below 25); (25-50); (51-75); (above 75)\] will be determined within a 24-hour timeframe in patients undergoing therapeutic paralysis. The concordance between PSI rates\* determined at baseline (time zero) and Richmond Agitation-Sedation Scale (RASS) \[(between -4 and -5); (between -3 and -2); (equal to or greater than -1)\] rates will be assessed. Suppression rate (SR) and electromyography (EMG) values will be obtained from patients, and significant differences among PSI groups \[(below 25); (25-50); (51-75); (above 75)\] in terms of these data will be examined. Additionally, changes in Propofol (mg/hour), Midazolam (mg/hour), Fentanyl (mg/hour), and Rocuronium (mg/hour) values will be analyzed for each time interval.

Trial Locations (1)

35640

Aykut Saritaş, Izmir

All Listed Sponsors
lead

Tepecik Training and Research Hospital

OTHER

NCT06337877 - "Assessment of Sedation Depth Using Processed EEG in ICU Patients With ARDS Receiving Neuromuscular Blockade: A Prospective Observational Study" | Biotech Hunter | Biotech Hunter